Access Resources
4801 - 4850 of 7540 Results
Title
Year
- Quantitative Proteomics of Presynaptic Mitochondria Reveal an Overexpression and Biological Relevance of Neuronal MitoNEET in Postnatal Brain Development2019RESTRICTEDTitle: Quantitative Proteomics of Presynaptic Mitochondria Reveal an Overexpression and Biological Relevance of Neuronal MitoNEET in Postnatal Brain DevelopmentJournal Name: Developmental NeurobiologyPublisher: WileyVol: 79Issue #: 4Start Page: 370End Page: 386Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/dneu.22684Best OA location URL: https://europepmc.org/articles/pmc6543812?pdf=renderCitation Count: 13
-
RESTRICTEDTitle: Self-reported physical activity levels and clinical progression in early Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 61Issue #:Start Page: 118End Page: 125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.006Citation Count: 53
- The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease2019RESTRICTEDTitle: The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's diseaseJournal Name: NeuroImagePublisher: Elsevier BVVol: 190Issue #:Start Page: 107End Page: 117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2017.12.012Best OA location URL: https://europepmc.org/articles/pmc6008164?pdf=renderCitation Count: 31
-
RESTRICTEDTitle: The virtual reality of Parkinson's disease freezing of gait: A systematic reviewJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 61Issue #:Start Page: 26End Page: 33Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.11.013Best OA location URL: https://europepmc.org/articles/pmc6773254?pdf=renderCitation Count: 22
-
RESTRICTEDTitle: Unknown fates of (brain) oxidation or UFO: Close encounters with neuronal senescenceJournal Name: Free Radical Biology and MedicinePublisher: Elsevier BVVol: 134Issue #:Start Page: 695End Page: 701Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.freeradbiomed.2019.01.012Citation Count: 16
- White Matter Changes Correlates of Peripheral Neuroinflammation in Patients with Parkinson’s Disease2019RESTRICTEDTitle: White Matter Changes Correlates of Peripheral Neuroinflammation in Patients with Parkinson’s DiseaseJournal Name: NeurosciencePublisher: Elsevier BVVol: 403Issue #:Start Page: 70End Page: 78Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2017.10.050Citation Count: 24
- Novel methods for integration and visualization of genomics and genetics data in Alzheimer's disease2019RESTRICTEDTitle: Novel methods for integration and visualization of genomics and genetics data in Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 15Issue #: 6Start Page: 788End Page: 798Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2019.01.011Best OA location URL: https://europepmc.org/articles/pmc6664293?pdf=renderCitation Count: 18
- l ‐3,4‐dihydroxyphenylalanine ( l ‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's disease2019RESTRICTEDTitle: l ‐3,4‐dihydroxyphenylalanine ( l ‐DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha‐synuclein mouse models of Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 150Issue #: 1Start Page: 88End Page: 106Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific, author manuscriptDOI - Digital Object Identifier: 10.1111/jnc.14676Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14676Citation Count: 25
-
RESTRICTEDTitle: Early Detection of Parkinson’s Disease by Using SPECT Imaging and BiomarkersJournal Name: Journal of Intelligent SystemsPublisher: Walter de Gruyter GmbHVol: 29Issue #: 1Start Page: 1329End Page: 1344Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1515/jisys-2018-0261Best OA location URL: https://www.degruyter.com/downloadpdf/journals/jisys/29/1/article-p1329.pdfCitation Count: 13
- The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort2019RESTRICTEDTitle: The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0077-5Best OA location URL: https://doi.org/10.1038/s41531-019-0077-5Citation Count: 32
- Comparative study of PROMISⓇ self-efficacy for managing chronic conditions across chronic neurologic disorders2019RESTRICTEDTitle: Comparative study of PROMISⓇ self-efficacy for managing chronic conditions across chronic neurologic disordersJournal Name: Quality of Life ResearchPublisher: Springer Science and Business Media LLCVol: 28Issue #: 7Start Page: 1893End Page: 1901Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11136-019-02164-2Best OA location URL: https://europepmc.org/articles/pmc7071345?pdf=renderCitation Count: 18
- Early Dyskinesias in Parkinson’s Disease Patients With Parkin Mutation: A Primary Corticostriatal Synaptopathy?2019RESTRICTEDTitle: Early Dyskinesias in Parkinson’s Disease Patients With Parkin Mutation: A Primary Corticostriatal Synaptopathy?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2019.00273Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2019.00273/pdfCitation Count: 9
- Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease2019RESTRICTEDTitle: Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 5Start Page: 704End Page: 714Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25450Best OA location URL: https://doi.org/10.1002/ana.25450Citation Count: 101
- A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson’s disease2019RESTRICTEDTitle: A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 15Start Page: 7419End Page: 7424Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1821778116Best OA location URL: https://www.pnas.org/content/pnas/116/15/7419.full.pdfCitation Count: 51
-
RESTRICTEDTitle: Targeting of the unfolded protein response (UPR) as therapy for Parkinson's diseaseJournal Name: Biology of the CellPublisher: WileyVol: 111Issue #: 6Start Page: 161End Page: 168Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/boc.201800068Citation Count: 36
- A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies2019RESTRICTEDTitle: A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologiesJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 5Start Page: 657End Page: 663Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27671Best OA location URL: https://lirias.kuleuven.be/bitstream/123456789/636637/2/Espay_et_al-2019-Movement_Disorders.pdfCitation Count: 207
-
RESTRICTEDTitle: The Parkinson's disease e‐diary: Developing a clinical and research tool for the digital ageJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 5Start Page: 676End Page: 681Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27673Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114172Citation Count: 43
-
RESTRICTEDTitle: Discovery of Volatile Biomarkers of Parkinson’s Disease from SebumJournal Name: ACS Central SciencePublisher: American Chemical Society (ACS)Vol: 5Issue #: 4Start Page: 599End Page: 606Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acscentsci.8b00879Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acscentsci.8b00879Citation Count: 101
- Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's Disease2019RESTRICTEDTitle: Molecular Neuroimaging of the Dopamine Transporter as a Patient Enrichment Biomarker for Clinical Trials for Early Parkinson's DiseaseJournal Name: Clinical and Translational SciencePublisher: WileyVol: 12Issue #: 3Start Page: 240End Page: 246Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/cts.12619Best OA location URL: https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cts.12619Citation Count: 15
- Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity2019RESTRICTEDTitle: Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicityJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 137Issue #: 6Start Page: 939End Page: 960Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-019-01993-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-019-01993-2.pdfCitation Count: 61
- The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease2019RESTRICTEDTitle: The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2019.00057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2019.00057/pdfCitation Count: 17
- DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood2019RESTRICTEDTitle: DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in bloodJournal Name: EpigeneticsPublisher: Informa UK LimitedVol: 14Issue #: 4Start Page: 365End Page: 382Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/15592294.2019.1588682Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15592294.2019.1588682?needAccess=trueCitation Count: 58
- The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT42019RESTRICTEDTitle: The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4Journal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-40808-yBest OA location URL: https://www.nature.com/articles/s41598-019-40808-y.pdfCitation Count: 20
-
RESTRICTEDTitle: Cholinergic system changes of falls and freezing of gait in Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 4Start Page: 538End Page: 549Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.25430Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25430Citation Count: 110
- Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings2019RESTRICTEDTitle: Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting ProceedingsJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-019-0476-1Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-019-0476-1Citation Count: 9
- Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes2019RESTRICTEDTitle: Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromesJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 90Issue #: 7Start Page: 768End Page: 773Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2018-320151Best OA location URL: https://jnnp.bmj.com/content/jnnp/90/7/768.full.pdfCitation Count: 29
- Pyridine-Fused 2-Pyridones via Povarov and A3 Reactions: Rapid Generation of Highly Functionalized Tricyclic Heterocycles Capable of Amyloid Fibril Binding2019RESTRICTEDTitle: Pyridine-Fused 2-Pyridones via Povarov and A3 Reactions: Rapid Generation of Highly Functionalized Tricyclic Heterocycles Capable of Amyloid Fibril BindingJournal Name: The Journal of Organic ChemistryPublisher: American Chemical Society (ACS)Vol: 84Issue #: 7Start Page: 3887End Page: 3903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.joc.8b03015Citation Count: 19
- Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein2019RESTRICTEDTitle: Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synucleinJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 12Issue #: 572Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scisignal.aau4543Best OA location URL: https://stke.sciencemag.org/content/sigtrans/12/572/eaau4543.full.pdfCitation Count: 120
- Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection2019RESTRICTEDTitle: Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotectionJournal Name: Cell ResearchPublisher: Springer Science and Business Media LLCVol: 29Issue #: 4Start Page: 313End Page: 329Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41422-019-0153-8Best OA location URL: https://www.nature.com/articles/s41422-019-0153-8.pdfCitation Count: 43
- Artificial Neural Network–Based Prediction of Outcome in Parkinson’s Disease Patients Using DaTscan SPECT Imaging Features2019RESTRICTEDTitle: Artificial Neural Network–Based Prediction of Outcome in Parkinson’s Disease Patients Using DaTscan SPECT Imaging FeaturesJournal Name: Molecular Imaging and BiologyPublisher: Springer Science and Business Media LLCVol: 21Issue #: 6Start Page: 1165End Page: 1173Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11307-019-01334-5Citation Count: 28
- Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis2019RESTRICTEDTitle: Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesisJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-08858-yBest OA location URL: https://www.nature.com/articles/s41467-019-08858-y.pdfCitation Count: 216
- Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's disease2019RESTRICTEDTitle: Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 536End Page: 544Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27646Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27646Citation Count: 144
- Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration2019RESTRICTEDTitle: Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 12Start Page: 5765End Page: 5774Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1814909116Best OA location URL: https://www.pnas.org/content/pnas/116/12/5765.full.pdfCitation Count: 75
-
RESTRICTEDTitle: Reduced habit-driven errors in Parkinson’s DiseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-019-39294-zBest OA location URL: https://www.nature.com/articles/s41598-019-39294-z.pdfCitation Count: 7
-
RESTRICTEDTitle: Higher urate in LRRK2 mutation carriers resistant to Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 4Start Page: 593End Page: 599Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25436Citation Count: 43
-
RESTRICTEDTitle: A comprehensive screening of copy number variability in dementia with Lewy bodiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 75Issue #:Start Page: 223.e1End Page: 223.e10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.10.019Best OA location URL: http://rihuc.huc.min-saude.pt/bitstream/10400.4/2247/1/comprehensive.pdfCitation Count: 12
-
RESTRICTEDTitle: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience DataJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 2Start Page: e28End Page: e29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088Citation Count: 0
-
RESTRICTEDTitle: An estimate of the total number of true human miRNAsJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 47Issue #: 7Start Page: 3353End Page: 3364Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/nar/gkz097Best OA location URL: https://academic.oup.com/nar/article-pdf/47/7/3353/28467549/gkz097.pdfCitation Count: 392
- Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptoms2019RESTRICTEDTitle: Benefits and risks of unilateral and bilateral ventral intermediate nucleus deep brain stimulation for axial essential tremor symptomsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 126End Page: 132Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.004Best OA location URL: http://manuscript.elsevier.com/S1353802018303894/pdf/S1353802018303894.pdfCitation Count: 30
- Depressive symptoms may increase the risk of the future development of freezing of gait in patients with Parkinson's disease: Findings from a 5-year prospective study2019RESTRICTEDTitle: Depressive symptoms may increase the risk of the future development of freezing of gait in patients with Parkinson's disease: Findings from a 5-year prospective studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 98End Page: 104Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.013Citation Count: 30
- Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trials2019RESTRICTEDTitle: Impact of dyskinesia on activities of daily living in Parkinson's disease: Results from pooled phase 3 ADS-5102 clinical trialsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 118End Page: 125Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.09.005Best OA location URL: http://www.prd-journal.com/article/S1353802018303900/pdfCitation Count: 22
- Interrogating the Genetic Determinants of Tourette’s Syndrome and Other Tic Disorders Through Genome-Wide Association Studies2019RESTRICTEDTitle: Interrogating the Genetic Determinants of Tourette’s Syndrome and Other Tic Disorders Through Genome-Wide Association StudiesJournal Name: American Journal of PsychiatryPublisher: American Psychiatric Association PublishingVol: 176Issue #: 3Start Page: 217End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.ajp.2018.18070857Best OA location URL: https://ajp.psychiatryonline.org/doi/pdf/10.1176/appi.ajp.2018.18070857Citation Count: 232
- Memory impairment in Parkinson’s disease: The retrieval versus associative deficit hypothesis revisited and reconciled.2019RESTRICTEDTitle: Memory impairment in Parkinson’s disease: The retrieval versus associative deficit hypothesis revisited and reconciled.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 33Issue #: 3Start Page: 391End Page: 405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000503Citation Count: 20
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2019RESTRICTEDTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://manuscript.elsevier.com/S1353802018304310/pdf/S1353802018304310.pdfCitation Count: 14
-
RESTRICTEDTitle: Prioritizing Parkinson’s disease genes using population-scale transcriptomic dataJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-08912-9Best OA location URL: https://www.nature.com/articles/s41467-019-08912-9.pdfCitation Count: 121
-
RESTRICTEDTitle: Real-World Experience With VMAT2 InhibitorsJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 42Issue #: 2Start Page: 37End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000326Citation Count: 33
-
RESTRICTEDTitle: Tau immunoreactivity in peripheral tissues of human aging and select tauopathiesJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 696Issue #:Start Page: 132End Page: 139Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2018.12.031Best OA location URL: https://europepmc.org/articles/pmc7357994?pdf=renderCitation Count: 34
- The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A2019RESTRICTEDTitle: The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8AJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 294Issue #: 13Start Page: 4738End Page: 4758Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.ra118.005008Best OA location URL: https://europepmc.org/articles/pmc6442034?pdf=renderCitation Count: 62
- Ultra–Low-Dose18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs2019RESTRICTEDTitle: Ultra–Low-Dose18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI InputsJournal Name: RadiologyPublisher: Radiological Society of North America (RSNA)Vol: 290Issue #: 3Start Page: 649End Page: 656Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1148/radiol.2018180940Best OA location URL: https://europepmc.org/articles/pmc6394782?pdf=renderCitation Count: 180
- Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways2019RESTRICTEDTitle: Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathwaysJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0675-9Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0675-9Citation Count: 13